The $12.56c. level was tested and (obviously) failed to hold ........the downward momentum remains dominant.
The next test of support is @ $11.80c. - $11.85c.
Just my take.
Cheers.
- Forums
- ASX - By Stock
- A2M
- Chart Update
Chart Update, page-7396
-
- There are more pages in this discussion • 17,835 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.86 |
Change
-0.025(0.36%) |
Mkt cap ! $4.959B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $7.625M | 1.103M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 4278 | $6.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.86 | 13591 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 3997 | 6.850 |
19 | 31489 | 6.840 |
14 | 33990 | 6.830 |
8 | 11242 | 6.820 |
11 | 79798 | 6.810 |
Price($) | Vol. | No. |
---|---|---|
6.860 | 13836 | 27 |
6.870 | 19915 | 21 |
6.880 | 39920 | 17 |
6.890 | 31595 | 13 |
6.900 | 38406 | 14 |
Last trade - 15.11pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online